drugset / Trial / NCT00796380

Clinical Study of Xingnaojing for the Treatment of Convulsive Diseases

NCT00796380 ↗

Phase 4 Unknown 1 enrolled Shenzhen Children's Hospital
RandomizedParallel-groupOpen-labelSupportive care

Summary

The purpose of this study is to evaluate the efficacy of Xingnaojing for the treatment of convulsive diseases; to investigate whether convulsion episodes can be induced or aggravated by Xingnaojing and the role inflammation plays in the process.

Timeline

Start
2008-12
Primary completion
2009-11
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Xingnaojing Unknown — Other

Indications